PLoS ONE (Jan 2019)

Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model.

  • Eun-Ju Choi,
  • Hyuek Jong Lee,
  • Wan-Jae Kim,
  • Kwon-Il Han,
  • Masahiro Iwasa,
  • Kazumasa Kobayashi,
  • Trishna Debnath,
  • Yujiao Tang,
  • Yi-Sub Kwak,
  • Jin-Hwan Yoon,
  • Eun-Kyung Kim

DOI
https://doi.org/10.1371/journal.pone.0210854
Journal volume & issue
Vol. 14, no. 2
p. e0210854

Abstract

Read online

Recent studies have demonstrated the immunomodulatory effects of heat-killed lactic acid bacteria. The aim of this study was to evaluate the protective effect of heat-killed Enterococcus faecalis EF-2001 (EF-2001) on a model of inflammatory bowel disease (IBD). A total of 28 female NC/Nga mice were divided into 4 treatment groups. Controls were fed a normal commercial diet. In the experimental groups, colitis was induced by rectal administration of dinitrobenzene sulfonic acid. Two groups were orally administered 2 and 17 mg/kg EF-2001, respectively. EF-2001 treatment decreased the expression of several cytokines, including cyclooxygenase (COX)-2, inducible nitric oxide synthase (iNOS), interferon (IFN)-γ, interleukin (IL)-1β, and IL-6 in inflamed colon compared to the DNBS alone group. In addition, EF-2001 suppressed DNBS-induced colonic tissue destruction. Therefore, this study strongly suggests that EF-2001 could alleviate the inflammation associated with mouse IBD.